NCT04126798 is a clinical trial of Behavioural in Vestibular Diseases, sponsored by University Hospital, Ghent.

Who is sponsoring NCT04126798?

NCT04126798 is sponsored by University Hospital, Ghent.

What drugs are being tested in NCT04126798?

Interventions in NCT04126798: Behavioural.

What condition does NCT04126798 study?

NCT04126798 studies Vestibular Diseases.

Is NCT04126798 still recruiting?

NCT04126798 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT04126798

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

2BALANCE: Cognitive-motor Dual-tasking in Persons with Vestibular Disorders

Completed Last updated 19 September 2024

What this trial tests

trial testing Behavioural in Vestibular Diseases in 130 participants. Completed in 15 June 2023.

Timeline

12 August 2019

Primary endpoint
15 April 2023

15 June 2023

Quick facts

Lead sponsor	University Hospital, Ghent
Status	Completed
Study type	OBSERVATIONAL
Enrollment	130
Start date	12 August 2019
Primary completion	15 April 2023
Estimated completion	15 June 2023
Sites	1 location across Belgium

Drugs / interventions tested

Behavioural

Conditions studied

Vestibular Diseases — all drugs for Vestibular Diseases →

Sponsor

University Hospital, Ghent

Who can join

Adults 18 to 65, any sex, with Vestibular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall aim of this study is to elucidate the impact of a vestibular dysfunction on the cognitive and motor performance by means of an extensive test protocol, evaluating the vestibular, cognitive and motor function using single as well as dual-task paradigms.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

2BALANCE: a cognitive-motor dual-task protocol for individuals with vestibular dysfunction.
Danneels M, Van Hecke R, Leyssens L, Degeest S, et al · · 2020 · cited 12× · PMID 32665391 · DOI 10.1136/bmjopen-2020-037138
The impact of vestibular function on cognitive-motor interference: a case-control study on dual-tasking in persons with bilateral vestibulopathy and normal hearing.
Danneels M, Van Hecke R, Leyssens L, van de Berg R, et al · · 2023 · cited 11× · PMID 37612342 · DOI 10.1038/s41598-023-40465-2

Verify or expand the search:

Other recruiting trials for Vestibular Diseases

Currently open trials in the same condition.

NCT05676944 — Vestibular Implantation in Older Adults · NA · recruiting
NCT05674786 — Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction · NA · recruiting
NCT05634902 — Implementation of Evidence-Based Practice for Dizziness · NA · active not recruiting
NCT03799991 — Vestibular Therapy in Alzheimer's Disease · NA · recruiting
NCT03716908 — Genotype-phenotype Correlation Study of Presymptomatic and Symptomatic DFNA9 Patients · recruiting

Other University Hospital, Ghent trials

Trials by the same sponsor.

NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04126798 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04126798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing